ライフサイエンスコーパス: antihypertensive medication

1 mm Hg, diastolic BP >or= 85 mm Hg, or use of antihypertensive medication).

2 0 mm Hg diastolic (n=10, of whom two were on antihypertensive medications).

3 ssure of at least 140/90 mm Hg or the use of antihypertensive medications).

4 blood pressure >/=90 mm Hg, or initiation of antihypertensive medications).

5 to ensure patient compliance with absence of antihypertensive medication.

6 adequate blood pressure control were CHD and antihypertensive medication.

7 mm Hg, diastolic BP >/= 90 mm Hg, or use of antihypertensive medication.

8 pressure of at least 90 mm Hg, or use of an antihypertensive medication.

9 an 140 mm Hg at 6 months; intensification of antihypertensive medication.

10 intensive BP lowering for many adults taking antihypertensive medication.

11 group developed a requirement for additional antihypertensive medication.

12 pressure of at least 140/90 mm Hg or use of antihypertensive medication.

13 Twenty-five participants (50%) were taking antihypertensive medication.

14 intensive BP lowering for many adults taking antihypertensive medication.

15 old males and females who reported no use of antihypertensive medication.

16 istribution for respondents reporting use of antihypertensive medication.

17 with low blood pressure who had never taken antihypertensive medication.

18 133 mm Hg, respectively, among those taking antihypertensive medication.

19 ition of a drug from any one of 5 classes of antihypertensive medication.

20 sion defined as self-reported treatment with antihypertensive medication.

21 overt cardiovascular disease, and no use of antihypertensive medication.

22 ients exhibited poor adherence to prescribed antihypertensive medications.

23 biennially updated data on hypertension and antihypertensive medications.

24 lic BP, female sex, anemia, and use of other antihypertensive medications.

25 BP >/=80 mm Hg or with self-reported use of antihypertensive medications.

26 d, coupled with significantly greater use of antihypertensive medications.

27 unt to choose adequate immunosuppressive and antihypertensive medications.

28 ed incidence of diabetes compared with other antihypertensive medications.

29 cident diabetes that develops while on other antihypertensive medications.

30 th incident hypertension who were started on antihypertensive medications.

31 Disease (PREVEND) study who were not taking antihypertensive medications.

32 on (aTRH) when subjects reported taking >/=3 antihypertensive medications.

33 tients were drug-naive or discontinued their antihypertensive medications.

34 herally acting drug amlodipine and for other antihypertensive medications.

35 compared with infants who had no exposure to antihypertensive medications.

36 -reported history of hypertension and use of antihypertensive medications.

37 d pressure of 90 mm Hg or greater, or taking antihypertensive medications.

38 ressure of 90 mm Hg or higher, or the use of antihypertensive medications.

39 lic blood pressure > or =90 mm Hg, or taking antihypertensive medications.

40 lower blood pressures and the need for fewer antihypertensive medications.

41 of blood pressure, as well as on evaluating antihypertensive medications.

42 d pressure </=130/85 mm Hg) and receiving no antihypertensive medications.

43 more frequent changes in the type or dose of antihypertensive medications.

44 od pressure after surgery while taking fewer antihypertensive medications.

45 ednisone; 32% of the patients were taken off antihypertensive medications.

46 es and mortality than those prescribed other antihypertensive medications.

47 Seventy-nine percent were not taking any antihypertensive medications.

48 ervation on blood pressure in the absence of antihypertensive medications.

49 the availability, cost, and prescription of antihypertensive medications.

50 s and 85 patients (75.9%) were taking ocular antihypertensive medications.

51 determine history of hypertension and use of antihypertensive medications.

52 Patients were withdrawn from antihypertensive medications 1 to 2 weeks before enrollm

53 to an increased uptake of treatments, mainly antihypertensive medication (12%) and initial treatments

54 lled 64 otherwise healthy patients taking no antihypertensive medications (31% women, 42% black, age

55 Among US adults taking antihypertensive medication, 53.4% (95% CI: 49.9% to 56.

56 Among U.S. adults taking antihypertensive medication, 53.4% (95% CI: 49.9% to 56.

57 jects and 5.3 among the 1,007 men not taking antihypertensive medication (95% confidence interval 1.8

58 ith hypertension who are not recommended for antihypertensive medication according to the 2017 ACC/AH

59 ith hypertension who are not recommended for antihypertensive medication according to the 2017 ACC/AH

60 for PM2.5 mass, age, body mass index, use of antihypertensive medication (ACE inhibitors, non-ophthal

61 he mechanism by which the various classes of antihypertensive medications achieve their effect, it re

62 ined the association between life events and antihypertensive medication adherence in older adults an

63 iews the effectiveness of methods to improve antihypertensive medication adherence, discusses the eff

64 evel on HT awareness, treatment, control, or antihypertensive medication adherence.

65 al, psychological, and biologic variables on antihypertensive medication adherence.

66 ypertension without further need of lifelong antihypertensive medications after adrenalectomy for ald

67 The presence of structural abnormalities or antihypertensive medication also correlated statisticall

68 Use of antihypertensive medications among patients with a histo

69 as significantly higher among men not taking antihypertensive medication; among men taking antihypert

70 ension control was defined as treatment with antihypertensive medication and a measured blood pressur

71 The use of antihypertensive medication and hypertension control has

72 ociation between initiating and intensifying antihypertensive medication and serious fall injuries in

73 proportion of individuals with resistance to antihypertensive medication and/or poor compliance or to

74 3362 sites, 8.1% (95% CI 7.2-9.1) stocked no antihypertensive medications and 33.8% (32.2-35.4) stock

75 cipants in the low target groups needed more antihypertensive medications and had a slightly higher r

76 oring was most effective in those with fewer antihypertensive medications and higher baseline sBP up

77 cal condition, thus discounting the value of antihypertensive medications and interfering with medica

78 for 4 medical exposures (oestrogen, statin, antihypertensive medications and non-steroidal anti-infl

79 e of comorbid conditions, and current use of antihypertensive medications and nonsteroidal anti-infla

80 We examined temporal trends in the use of antihypertensive medications and studied the relation be

81 ansplantation occurred despite a decrease in antihypertensive medications and the institution of immu

82 patients (57.7%) were completely weaned-off antihypertensive medications and their use dropped from

83 ssure of at least 140/90 mm Hg or the use of antihypertensive medication) and subjects without hypert

84 betes, 54% had hypertension (47% were taking antihypertensive medications), and 60% had hyperlipidemi

85 (or 85 to 105 mm Hg if the woman was taking antihypertensive medications), and a live fetus.

86 d drug treatment: 86% used statins, 90% used antihypertensive medication, and 98% used antithrombotic

87 They also received more antihypertensive medication, and a greater proportion re

88 terol), mean arterial blood pressure, use of antihypertensive medication, and baseline brachial arter

89 ed diagnosis of hypertension, current use of antihypertensive medication, and blood pressure of less

90 duration, smoking, systolic blood pressure, antihypertensive medication, and BMI.

91 d pressure (BP) thresholds for initiation of antihypertensive medication, and BP target goals.

92 s who had high blood pressure or were taking antihypertensive medication, and control subjects were i

93 high-risk threshold after receiving aspirin, antihypertensive medication, and estrogen-replacement th

94 he percentage of U.S. adults recommended for antihypertensive medication, and more intensive BP lower

95 the percentage of US adults recommended for antihypertensive medication, and more intensive BP lower

96 tension, implications of recommendations for antihypertensive medication, and prevalence of BP above

97 tension, implications of recommendations for antihypertensive medication, and prevalence of BP above

98 atment received an average of one additional antihypertensive medication, and the systolic blood pres

99 is, 30.1% (30.0-30.2) were taking prescribed antihypertensive medications, and 7.2% (7.1-7.2) had ach

100 ibodies, discontinuation of antiplatelet and antihypertensive medications, and any increase of 1 trad

101 re obtained on blood pressure and the use of antihypertensive medications, and electrocardiograms wer

102 The patients were treated with antihypertensive medications, and immunosuppressive ther

103 Information on hypertension history, use of antihypertensive medications, and potential confounders

104 tes, angiographic stenoses, blood pressures, antihypertensive medications, and serum creatinine level

105 ted for conventional AF risk factors, use of antihypertensive medications, and serum potassium.

106 n of examination, state of residence, use of antihypertensive medications, and smoking status.

107 function, blood pressure control, number of antihypertensive medications, and survival.

108 PP, duration of diabetes, gender, number of antihypertensive medications, and use of angiotensin-con

109 ts with high blood pressure (BP) do not have antihypertensive medications appropriately intensified a

110 Older age, lower registration LVEF, and antihypertensive medications are associated with increas

111 Several antihypertensive medications are commercially available

112 ontinuation of gemcitabine, the provision of antihypertensive medications as needed, and consideratio

113 ars (nearly a quarter of program spending on antihypertensive medications), as well as being more cli

114 of participants with diabetes were receiving antihypertensive medication at recruitment and 1% were r

115 lood pressure before transplant were off all antihypertensive medications at 1 year after transplant.

116 ility, cost, and prescription patterns of 62 antihypertensive medications at primary health-care site

117 130 to 180 mm Hg (depending on the number of antihypertensive medications being taken), and high card

118 lts with hypertension, differences in use of antihypertensive medications between continuously uninsu

119 n weight, serum cholesterol, and (along with antihypertensive medication) blood pressure reduced the

120 our readily available predictors (2 or fewer antihypertensive medications, body mass index < or =25 k

121 tolic blood pressure <80 mm Hg and not using antihypertensive medications, body mass index <25 kg/m(2

122 ce (blood pressure > or =160/95 and/or using antihypertensive medication) by education was calculated

123 130 to 180 mm Hg depending on the number of antihypertensive medication classes being taken, and hig

124 f US hypertensive adults took a prescription antihypertensive medication compared with 57.3% during 1

125 with less requirement for lipid-lowering and antihypertensive medication compared with cyclosporine,

126 ease, self-monitoring with self-titration of antihypertensive medication compared with usual care res

127 be challenging and recommendations regarding antihypertensive medications continue to evolve.

128 We sought to determine whether antihypertensive medications could be used more effectiv

129 Antihypertensive medication data were obtained from all

130 le score (age, sex, systolic blood pressure, antihypertensive medication, diabetes mellitus, cigarett

131 ent smoking, systolic blood pressure, use of antihypertensive medication, diabetes mellitus, serum po

132 physical activity, systolic blood pressure, antihypertensive medications, diabetes mellitus, diabeti

133 cohol intake, triglyceride level, and use of antihypertensive medication did not materially alter the

134 Use of antihypertensive medication did not modify the relations

135 In contrast, fetal exposure to other antihypertensive medications during only the first trime

136 variant was associated with modification of antihypertensive medication effects on cardiovascular di

137 s have an elevated risk of hypertension, and antihypertensive medications, especially beta-blockers,

138 Antihypertensive medications evaluated included beta-blo

139 who fail to take their prescribed statin and antihypertensive medication experience a substantially i

140 Current guidelines for prescribing antihypertensive medications focus on reaching specific

141 All patients were maintained on the same antihypertensive medications for 3 months before the stu

142 We screened 55 clinically prescribed antihypertensive medications for AD-modifying activity u

143 Act has led to the study and approval of new antihypertensive medications for use in pediatrics.

144 olution of hypertension without the need for antihypertensive medications from patients that will req

145 Children on antihypertensive medication had impaired physical functi

146 mpared with controls, participants receiving antihypertensive medications had a pooled relative risk

147 upport the notion that the increasing use of antihypertensive medication has resulted in a reduced pr

148 To date, no specific antihypertensive medications have been shown to be more

149 yet only about 50% of patients treated with antihypertensive medications have their blood pressure c

150 al activity, seated systolic blood pressure, antihypertensive medications, hematocrit, alcohol intake

151 n to lower blood pressure with >/=1 class of antihypertensive medication identified through a pill bo

152 ystolic blood pressure in subjects not using antihypertensive medication in unadjusted (133.7+/-20.7

153 led more than 2.05 million prescriptions for antihypertensive medications in 2001, at an annual progr

154 rn preterm were more likely to be prescribed antihypertensive medications in 2005-2009 than those bor

155 t current patterns of access to, and use of, antihypertensive medications in Chinese primary health c

156 t that there are differences in adherence to antihypertensive medications in different classes.

157 ugh few data exist on efficacy and safety of antihypertensive medications in neonates, a wide variety

158 espite the greater use of lipid-lowering and antihypertensive medications in the cyclosporine group.

159 er alone, 202 infants with exposure to other antihypertensive medications in the first trimester alon

160 The need for antihypertensive medications in two of these seven poten

161 e of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the interventi

162 The most commonly used antihypertensive medications included diuretics, angiote

163 From 1950 to 1989, the rate of use of antihypertensive medications increased from 2.3 percent

164 njury was increased during the 15 days after antihypertensive medication initiation (odds ratio, 1.36

165 ilable on the short-term risk of falls after antihypertensive medication initiation and intensificati

166 Antihypertensive medication initiation and intensificati

167 Antihypertensive medication initiation was defined by a

168 erence and treatment intensification (TI) of antihypertensive medications is associated with blood pr

169 patients that will require continued use of antihypertensive medications is difficult before adrenal

170 ave reported that blood pressure response to antihypertensive medications is influenced by genetic va

171 Patient adherence to antihypertensive medications is not associated with BP c

172 plant recipients receiving ACEI/ARB or other antihypertensive medications is virtually identical.

173 plant recipients receiving ACEI/ARB or other antihypertensive medications is virtually identical.

174 k, education on hypertension, prescribing of antihypertensive medications, laboratory monitoring, and

175 ormed in 3935 subjects who were not using an antihypertensive medication, lipid-lowering drugs, or a

176 cular disease event reduction) approaches to antihypertensive medication management.

177 Some of the beneficial effect of taking antihypertensive medication may have been due to reducin

178 epidemiological evidence suggests that some antihypertensive medications may reduce the risk for Alz

179 d with higher blood pressure, such as use of antihypertensive medications--may reduce AD risk.

180 A total of 101 (85%) patients were receiving antihypertensive medications (median 2), and 85 (71%) ac

181 bject with severe hypertension refractory to antihypertensive medications, monotherapy with NO supple

182 e at follow-up, as defined as treatment with antihypertensive medications (n=8) or average blood pres

183 netics and pharmacodynamics of the different antihypertensive medications need to be carefully consid

184 blood pressure 120/</=80 mm Hg and no use of antihypertensive medication; no current smoking; and no

185 sradipine, a general LTCC antagonist used as antihypertensive medication, not only blocks the inducti

186 Antihypertensive medication number and percentages on >/

187 nfidence interval: 2.15-17), and about their antihypertensive medications (odds ratio: 6.48; 95% conf

188 ombination of at least three optimally dosed antihypertensive medications, one of which is a diuretic

189 Hypertensive status was defined as use of antihypertensive medication or measured BP > or =140/90

190 eneficiaries initiated, added a new class of antihypertensive medication or titrated therapy within 1

191 e in men and women, whether they were taking antihypertensive medications or not, and, independent of

192 ected differentially by different classes of antihypertensive medications or treatment with statins.

193 or more follow-up visits, or treatment with antihypertensive medication, or a cardiovascular event d

194 P of at least 90 mm Hg, self-reported use of antihypertensive medications, or both.

195 tricted to those with hypertension or taking antihypertensive medications: OR = 4.20 (95% CI: 1.28 to

196 ssure less than 90 mm Hg who were not taking antihypertensive medications, oral hypoglycemic medicati

197 Use of antihypertensive medication other than diuretic agents w

198 dex included systolic BP, anemia, and use of antihypertensive medications other than angiotensin-conv

199 sociated with a higher probability of taking antihypertensive medication (p = 6.7 x 10(-8)).

200 ne or more adjustments of insulin (P=0.006), antihypertensive medications (P<0.001), and antidepressa

201 e clear guidelines and an array of available antihypertensive medications, patients with hypertension

202 will need to improve access to, and use of, antihypertensive medications, paying particular attentio

203 12 mm Hg (p < 0.001); and the mean number of antihypertensive medications per patient from 2.6 +/- 1

204 creas transplantation, the average number of antihypertensive medications per patient was 0.9+/-1.0,

205 rn preterm had an increased relative rate of antihypertensive medication prescription that increased

206 pressure, cholesterol concentration, use of antihypertensive medication, recreational exercise, non-

207 ealthy patients up to age 85 years with most antihypertensive medications reduces cardiovascular morb

208 ine, mean blood pressure, and mean number of antihypertensive medications required before and after c

209 acceptable patient BP control and minimizing antihypertensive medication requirements.

210 tically reduce, and in many cases eliminate, antihypertensive medication requirements.

211 60.1-76.0) among those taking and not taking antihypertensive medication, respectively.

212 and 10% (7-13%) among nonusers and users of antihypertensive medications, respectively.

213 95% CI, 0.959-0.977), number of preoperative antihypertensive medications (RYGB: OR, 0.104; 95% CI, 0

214 Patients on antihypertensive medication seem to be the most vulnerab

215 c characteristics (age, sex, income); use of antihypertensive medication; smoking; tooth loss; dental

216 d as either new diagnosis, the initiation of antihypertensive medication, systolic blood pressure > o

217 nt was both more effective and required less antihypertensive medication than current guidelines base

218 hypertension were still less likely to take antihypertensive medication than non-Hispanic whites wit

219 Recent studies suggest that antihypertensive medications that reduce albumin excreti

220 scular deficits in AD.SIGNIFICANCE STATEMENT Antihypertensive medications that target the renin angio

221 Among participants not taking antihypertensive medication, the regression-derived thre

222 Among participants taking antihypertensive medication, the regression-derived thre

223 of prednisone, the number of patients taking antihypertensive medications, the average number of epis

224 tion of one of the most effective classes of antihypertensive medications, thiazide diuretics.

225 nts with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90

226 imely initiation and subsequent titration of antihypertensive medications to achieve individualised B

227 large number of patients continue to require antihypertensive medications to control their blood pres

228 f hypertension, use of diuretics, and use of antihypertensive medications to the risk of fatal renal

229 stolic blood pressure >/=90 mm Hg, or use of antihypertensive medications to treat high blood pressur

230 itating improvements in patient adherence to antihypertensive medications, to provide a framework for

231 everity, background hypertension prevalence, antihypertensive medication treatment, case fatality, in

232 art disease and stroke risk reduction due to antihypertensive medication treatment.

233 Men had the greatest increase in antihypertensive medication use (47.5%, 1988-1994 versus

234 cigarettes smoked (P for trend < 0.001), and antihypertensive medication use (P < 0.001).

235 but not history of hypertension (P =.53) or antihypertensive medication use (P =.77).

236 This study examined trends in prescribed antihypertensive medication use among US adults with hyp

237 Antihypertensive medication use and multiple antihypertensive medication use among US hypertensive ad

238 Antihypertensive medication use and blood pressure contr

239 f this study was to examine recent trends in antihypertensive medication use and its impact on blood

240 onducted to estimate the association between antihypertensive medication use and markers of increased

241 Antihypertensive medication use and multiple antihyperte

242 asting insulin concentrations, diabetes, and antihypertensive medication use but became nonsignifican

243 Antihypertensive medication use has been associated with

244 The adjusted associations between antihypertensive medication use in aggregate and 3 or mo

245 e, beta-blocker, ACE-inhibitor, diuretic, or antihypertensive medication use in aggregate remained as

246 icant decrease in systolic blood pressure or antihypertensive medication use in the patients receivin

247 ssure of at least 90 mm Hg, or self-reported antihypertensive medication use in the previous 2 weeks.

248 of diabetes mellitus, history of stroke, and antihypertensive medication use increased at higher low-

249 The prevalence of antihypertensive medication use increased from 63.5% in

250 In both surveys, antihypertensive medication use increased with age, was

251 n emergency department anaphylaxis patients, antihypertensive medication use is associated with incre

252 Antihypertensive medication use rose to >50% among all a

253 These men had no history of CVD or antihypertensive medication use through the time of the

254 iastolic dimensions with increasing age; and antihypertensive medication use was a marker of an atten

255 Antihypertensive medication use was self-reported.

256 , body mass index, blood pressure (including antihypertensive medication use), smoking, and diabetes

257 BP> or =140 or diastolic BP> or =90 mm Hg or antihypertensive medication use).

258 ng for age, randomized treatment assignment, antihypertensive medication use, and coronary risk facto

259 lcohol consumption, systolic blood pressure, antihypertensive medication use, diabetes mellitus, and

260 olic blood pressure, current smoking status, antihypertensive medication use, diabetes mellitus, hist

261 ressure, fasting glucose, total cholesterol, antihypertensive medication use, glomerular filtration r

262 rs, including age, body mass index, smoking, antihypertensive medication use, or C-reactive protein l

263 al fibrillation, valvular heart disease, and antihypertensive medication use, pulse pressure was an i

264 relationship of OH with elevated BP, but not antihypertensive medication use, suggests that the treat

265 , and sex), traditional stroke risk factors (antihypertensive medication use, systolic blood pressure

266 influences of sex, age, body mass index, and antihypertensive medication use, the SFI was significant

267 , sex, tobacco use, systolic blood pressure, antihypertensive medication use, total and high-density

268 Analyses were stratified by antihypertensive medication use.

269 ased on average blood pressure >/=140/90 and antihypertensive medication use.

270 ies, body mass index, SBP, diastolic BP, and antihypertensive medication use.

271 body mass index, vascular risk factors, and antihypertensive medication use.

272 In replication, baseline antihypertensive medication users in the supplementation

273 The lifetime probability of receiving antihypertensive medication was 60%.

274 Withdrawal of antihypertensive medication was attempted after 3 months

275 A pharmacometabolomics study of antihypertensive medication was conducted and data were

276 Low adherence to antihypertensive medication was defined as scores less t

277 ctorial intervention to improve adherence to antihypertensive medication was effective in improving b

278 (95% CI: 30.1% to 33.7%), respectively, and antihypertensive medication was recommended for 36.2% (9

279 (95% CI: 30.1% to 33.7%), respectively, and antihypertensive medication was recommended for 36.2% (9

280 Antihypertensive medication was required in 4 of 19 chil

281 In a separate analysis, the use of antihypertensive medications was independently associate

282 The number of antihypertensive medications was initially reduced on av

283 = 26) at 12 months, p < 0.01; the number of antihypertensive medications was significantly lower in

284 ic ethnicity and requirement for more than 1 antihypertensive medication were independently associate

285 Significant predictors of receiving antihypertensive medication were: increasing age, female

286 registration LVEF less than 65%, and use of antihypertensive medications were associated with an inc

287 Blood pressure measurements and all antihypertensive medications were determined for both gr

288 Antihypertensive medications were discontinued before st

289 mal volunteers and 15 hypertensive subjects (antihypertensive medications were discontinued for more

290 on (blood pressure > or =140/90 mm Hg or new antihypertensive medication) were calculated.

291 h pre- or stage 1 hypertension and not using antihypertensive medications, were randomized to either

292 Reduction of >/=30% of the total number of antihypertensive medications while maintaining controlle

293 s reduction of >/=30% of the total number of antihypertensive medications while maintaining systolic

294 Among participants taking antihypertensive medication with SBP/DBP <140/90 mm Hg,

295 sociation of prior existing hypertension and antihypertensive medications with risk of incident psori

296 ontrolled blood pressure despite use of >/=3 antihypertensive medications, with data collected on pre

297 .6%) FMD patients have subsequently required antihypertensive medications, with one requiring angiopl

298 The adjusted odds ratio for >/=1 antihypertensive medications/year ranged from 1.25 (95%